Oren Hershkovitz
Vorstandsvorsitzender bei ENLIVEX THERAPEUTICS LTD.
Vermögen: 27 778 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Oren Hershkovitz
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 15 | |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Oren Hershkovitz
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BIO-REFERENCE LABORATORIES INC | Medical/Nursing Services | Director/Board Member Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Presstek LLC
Presstek LLC Industrial MachineryProducer Manufacturing Presstek LLC supplies digital offset printing solutions for the printing and communications industries. Its solutions include commercial printers, in plants, packaging, digital, franchise printers, and mailing services. The firm also offers inkjet, commercial CTP, commercial plates, newspaper plates, workflow, conventional offset products, and finishing equipment. The company was founded by Lawrence A. Howard in 1987 and is headquartered in Hudson, CT. | Industrial Machinery | Corporate Officer/Principal | |
Thomas Jefferson University | College/University | Corporate Officer/Principal | |
MOLECULAR PHARMACOLOGY (USA), LTD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Janssen R&D Ireland Ltd. | President | ||
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Pluristem Ltd.
Pluristem Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pluri, Inc., Pluristem Ltd. is an Israeli company that sources therapeutic cells from the placenta to create cell-based products for commercial use. The private company is based in Haifa, Israel and was founded by Yoram Nathan Drucker. The company's patented and validated 3D cell expansion system is designed to mimic the human body, and its cell therapies have potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation. Pluristem's method is uniquely accurate, cost-effective, and consistent from batch to batch. Pluristem was acquired by Pluri, Inc. on June 23, 2003. | Miscellaneous Commercial Services | General Counsel | |
The Johns Hopkins University | College/University | Undergraduate Degree | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
OPKO HEALTH, INC. | Medical/Nursing Services | Chief Administrative Officer Director of Finance/CFO Corporate Officer/Principal | |
Sidney Kimmel Medical College | College/University | Corporate Officer/Principal | |
GAMIDA CELL LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Institute of Human Virology
Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Other Consumer Services | Chairman | |
Hadassah University Hospital
Hadassah University Hospital Hospital/Nursing ManagementHealth Services Hadassah University Hospital engages in the operation of hospitals and medical centers in Israel and abroad. Its services include hospitalization services, medical services, medical tourism, and research and development. The company was founded in 1934 and is headquartered in Jerusalem, Israel. | Hospital/Nursing Management | Corporate Officer/Principal | |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer | |
Stentomics, Inc. | Founder | ||
Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | ||
Tibotec Pharmaceuticals | Chief Executive Officer | ||
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Medical Specialties | Director/Board Member | |
The College of Management Academic Studies | College/University | Masters Business Admin | |
COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member | |
SERES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
Pavilion Data Systems, Inc.
Pavilion Data Systems, Inc. Packaged SoftwareTechnology Services Pavilion Data Systems, Inc. designs and develops NVMe-oF storage technologies. Its NVMe-over-Fabric Storage Array ingests, processes, stores, and serves an order of magnitude more data for massively-parallel, modern applications. The company was founded by Kiran Malwankar, V. R. Satish, and Sundar Kanthadai in 2014 and is headquartered in San Jose, CA. | Packaged Software | Director/Board Member | |
VBI VACCINES INC. | Biotechnology | Director/Board Member Director/Board Member | |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
SECULETTER CO., LTD. | Packaged Software | Director/Board Member | |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chairman | |
Janssen Therapeutics, Inc. | President | ||
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Biotechnology | Director/Board Member | |
Pomerantz Life Sciences Consulting Group LLC | President | ||
VIRACTA THERAPEUTICS, INC. | Biotechnology | Chairman | |
INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Verimmune, Inc.
Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 32 |
Israel | 14 |
Irland | 3 |
Australien | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 25 |
Consumer Services | 9 |
Health Services | 5 |
Commercial Services | 3 |
Technology Services | 3 |
Operativ
Director/Board Member | 82 |
Independent Dir/Board Member | 32 |
Chairman | 20 |
Corporate Officer/Principal | 18 |
Chief Executive Officer | 12 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Steven Rubin | 37 |
Roger Pomerantz | 30 |
Avri Havron | 14 |
Shai Novik | 13 |
Sangwoo Lee | 12 |
Gili Hart | 11 |
Brian Schwartz | 9 |
Adam Logal | 8 |
Andrew Singer | 7 |
Oren Elmaliah | 6 |
Steve Schaeffer | 5 |
Dror Mevorach | 4 |
Shachar Shlosberger | 3 |
Einat Galamidi | 3 |
Shmuel Hess | 2 |
- Börse
- Insiders
- Oren Hershkovitz
- Unternehmensverbindungen